Jason Amello insider trades
Open-market stock purchases and sales by Jason Amello, Chief Financial Officer at TScan Therapeutics, Inc, from SEC Form 4 filings since May 24, 2010.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -94%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 20, 2026 | TCRX TScan Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TCRX TScan Therapeutics, Inc: other filings, last Jan 20, 2026
- CADL Candel Therapeutics, Inc: 2 buys, last Nov 28, 2023
- ACER Acer Therapeutics Inc: other filings, last Mar 14, 2023
- AKBA Akebia Therapeutics, Inc: 2 buys, 1 sale, last Feb 28, 2020
- ZIOP Ziopharm Oncology Inc: other filings, last May 8, 2013
- GENZ Genzyme Corp: 2 sales, last Apr 4, 2011